[Proatherothrombogenic effects of remnant lipoproteins on endothelial cells].
Kugiyama
K
K
Department of Cardiovascular Medicine, Kumamoto University School of Medicine.
D000818:Animals; D001053:Apolipoproteins / Q000494:pharmacology / Q000502:physiology; D001161:Arteriosclerosis / Q000209:etiology; D002784:Cholesterol; D003327:Coronary Disease / Q000209:etiology; D004730:Endothelium, Vascular / Q000502:physiology; D006801:Humans; D008074:Lipoproteins / Q000494:pharmacology / Q000502:physiology; D009569:Nitric Oxide / Q000378:metabolism; D012306:Risk; D014280:Triglycerides / Q000494:pharmacology / Q000502:physiology; D014664:Vasodilation / Q000187:drug effects
D001053:Apolipoproteins; D008074:Lipoproteins; D014280:Triglycerides; C112017:remnant-like particle cholesterol; D009569:Nitric Oxide; D002784:Cholesterol